TRIUMPH
LIVE

Serial Number

97668847

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Nov 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TRIUMPH Trademark

Serial Number: 97668847

TRIUMPH is a trademark filed by Seqirus Inc. on November 8, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (84 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

November 8, 2022

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use

Medical services; medical information; providing a website featuring medical information

Filing History

SOU TEAS EXTENSION RECEIVED
May 21, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 30, 2026 EX4G
SOU EXTENSION 4 FILED
Jan 30, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 30, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2025 EXRA
SOU EXTENSION 3 GRANTED
Aug 8, 2025 EX3G
SOU EXTENSION 3 FILED
Aug 8, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 2, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 2, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 16, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 16, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2023 CNRT
ASSIGNED TO EXAMINER
May 15, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 21, 2023 AMPX
ASSIGNED TO LIE
Feb 21, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 15, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2022 NWOS
NEW APPLICATION ENTERED
Nov 11, 2022 NWAP